Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 044 550.9 |
| 96 | EP file number | EAKZ | 09 07 5549.7 |
| 97 | EP publication number | EPN | 2191844 |
| 54 | Designation/title | TI | Injizierbarer Impfstoff gegen multiple Meningokokken-Serogruppen |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/095 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 39/39 (2006.01), C07K 14/22 (2006.01), A61K 39/02 (2006.01), A61K 39/09 (2006.01) |
| 22 | DE application date | DAT | Jan 30, 2004 |
| 96 | EP application date | EAT | Jan 30, 2004 |
| 43 | Date of first publication | OT | Jun 2, 2010 |
| Date of publication of grant | PET | Mar 5, 2014 |
| 71/73 | Applicant/owner | INH | GlaxoSmithKline Biologicals S.A., Rixensart, BE |
| 72 | Inventor | IN | Costantino, Paolo, 53100 Siena, IT |
| 74 | Representative | VTR | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| GB
0323101
Oct 2, 2003
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| GB
0302217
Jan 30, 2003
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002191844
Searchable text:
EP000002191844
Original document:
EP000002191844B1
Searchable text:
EP000002191844B1 |
| 43 | Date of first publication | EVT | Jun 2, 2010 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 1, 2024
(Show all update days)(Hide all update days)- May 27, 2011
- Date of the first transfer into DPMAregister
|
